These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 190881)

  • 1. Conversion of angiotensin I to angiotensin II.
    Erdös EG
    Am J Med; 1976 May; 60(6):749-59. PubMed ID: 190881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin I converting enzyme.
    Erdös EG
    Fed Proc; 1977 Apr; 36(5):1760-5. PubMed ID: 191298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine].
    Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP
    Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme.
    Dorer FE; Kahn JR; Lentz KE; Levine M; Skeggs LT
    Biochem Pharmacol; 1975 May; 24(10):1137-9. PubMed ID: 168899
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey.
    Bakhle YS
    Ciba Found Symp; 1980; 78():275-92. PubMed ID: 6258881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
    Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
    Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
    Shaltout HA; Westwood BM; Averill DB; Ferrario CM; Figueroa JP; Diz DI; Rose JC; Chappell MC
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F82-91. PubMed ID: 16896185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats.
    Aihara H; Ogawa H; Kasuya A; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    Eur J Pharmacol; 1999 May; 373(1):35-40. PubMed ID: 10408249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of renin: recent developments.
    Hofbauer KG; Wood JM
    Contrib Nephrol; 1984; 43():144-52. PubMed ID: 6207982
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
    Lembeck F; Griesbacher T; Eckhardt M
    Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular angiotensin receptors and their role in blood pressure control.
    Thurston H
    Am J Med; 1976 Nov; 61(5):768-78. PubMed ID: 185902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abolition of long-term vascular influence of renin-angiotensin system.
    Randall RD; Zimmerman BG
    Am J Physiol; 1990 Aug; 259(2 Pt 2):H543-53. PubMed ID: 2167025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme, angiotensin II and hypertensive disease.
    Soffer RL; Case DB
    Am J Med; 1978 Jan; 64(1):147-160. PubMed ID: 203191
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
    Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
    N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.